Abstract
Tumorous human breast tissue readily converts progesterone to 5α-pregnane-3,20-dione (5αP), and this metabolite has been shown to stimulate proliferation and to decrease adhesion of MCF-7 breast cancer cells. To determine the mechanisms of action of 5αP on cell adhesion, MCF-7 cells were grown without or with 5αP (10−9–10−5 M), and the effects on cell and nuclear morphology, adhesion plaques, vinculin and actin expression, actin polymerization, and microfilament distribution were examined by immunohistochemistry, morphometry (using confocal microscopy and digital computer imaging analysis), and Western blotting. Treatment of cells with 10−9–10−6 M 5αP resulted in dose-dependent decreases in cell area, cell-to-cell contacts, and attachment to the substratum, and increases in variation in nuclear area. These changes in the 5αP-treated cells were accompanied by decreases in vinculin-containing adhesion plaques, vinculin expression, polymerized actin stress fibers, and decreases in insoluble and increases in soluble actin fractions. The results suggest that the observed decreases in adhesion and increases in cell proliferation following 5αP treatment may be owing to depolymerization of actin and decreased expression of actin and vinculin. We conclude that the endogenous progesterone metabolite, 5αP, may be involved in promoting breast neoplasia and metastasis by affecting adhesion and cytoskeletal molecules.
Similar content being viewed by others
References
Going, J. J., Anderson, T.J., Battersby, S., and MacIntyre, C. C. A. (1988). Am. J. Pathol. 130, 193–204.
Potten, C. S., Watson, R. J., Williams, G. T., Tickle, S., Roberts, S. A., Harris, M., and Howel, A. (1988). Br. J. Cancer 58, 163–170.
Pike, M. C., Spicer, D. V., Dahmoush, L., and Press, M. F. (1993). Epidemiol. Rev. 15, 17–35.
King, R. J. B. (1991). J. Steroid Biochem. Mol. Biol. 39, 811–818.
Santen, R. J., Manni, A., Harvey, H., and Redmond, C. (1990). Endocr. Rev. 11, 221–265.
Anderson, T. J., Battersby, S., King, R. J. B., McPherson, K., and Going, J. J. (1989). Hum. Pathol. 20, 1139–1144.
Groshong, S. D., Owen, G. I., Grimison, B., Schauer, I. E., Todd, M. C., Langan, T. A., Sclafani, R. A., Lange, C. A., and Horwitz, K. B. (1997). Mol. Endocrinol. 11, 1593–1607.
Braunsberg, H., Coldham, N. G., Leake, R. E., Cowan, S. K., and Wong, W. R. (1987). Eur. J. Cancer Clin. Oncol. 23, 563–572.
Clark, C. L. and Sutherland, R. L. (1990). Endocr. Rev. 11, 266–302.
Cappelletti, V., Miodini, P., Fioravanti, L., and Di Fronzo, G. (1995). Anticancer Res. 15, 2551–2556.
Musgrove, E. A. and Sutherland, R. L. (1994). Semin. Cancer Biol. 5, 381–389.
Wiebe, J. P., Muzia, D., Hu, J., Szwajcer, D., Hill, S. A., and Seachrist, J. L. (2000). Cancer Res. 60, 936–943.
Weiler, P. J. and Wiebe, J. P. (2000). Biochem. Biophys. Res. Commun. 272, 731–737.
Fox, C. H., Caspersson, T., Kudynowski, J., Sanford, K. K., and Tarone, R. E. (1977). Cancer Res. 37, 892–897.
Folkman, J. and Moscona, A. (1978). Nature 273, 345–349.
Baak, J. P., Van Dop, H., and Kurver, P. H. (1985). Cancer 56, 374–382.
Iwig, M., Czeslick, E., Muller, A., Gruner, M., Spindler, M., and Glaesser, D. (1995). Eur. J. Cell Biol. 67, 145–157.
Dewhurst, L. O., Rennie, I. G., and MacNeil, S. (1998). Melanoma Res. 8, 303–311.
Ben-Ze’ev, A. (1985). Biochim. Biophys. Acta 780, 197–212.
Holme, T. C. (1990). Eur. J. Surg. Oncol. 16, 161–169.
Lin, Z. X. (1993). Chin. J. Oncol. 15, 8–11.
Holth, L. T., Chadee, D. N., Spencer, V. A., Samuel, S. K., Safneck, J. R., and Davie, J. R. (1998). Int. J. Oncol. 13, 827–837.
Burridge, K. (1986). Cancer Rev. 4, 18–78.
Ráz, A. (1988). Ciba Found. Symp. 141, 109–122.
Suzuki, H., Nagata, H., Shimada, Y., and Konno, A. (1998). Int. J. Oncol. 12, 1079–1084.
Wilkins, J. A. and Lin, S. (1982). Cell 28, 83–90.
Luna, E. J. and Hitt, A. L. (1992). Science 258, 955–964.
Humphries, M. J. and Newham, P. (1998). Trends Cell Biol. 8, 78–83.
Schliwa, M., Nakamura, T., Porter, K. R., and Euteneuer, V. (1984). J. Cell Biol. 99, 1045–1059.
Sadano, H., Inoue, M., and Taniguchi, S. (1992). Jap. J. Cancer Res. 83, 625–630.
Sapino, A., Pietribiasi, F., Bussolati, G., and Marchisio, P. C. (1986). Cancer Res. 46, 2526–2531.
Koukouritaki, S. B., Margoris, A. N., Gravanis, A., Hartig, R., and Stournaras, C. (1997). J. Cell. Biochem. 65, 492–500.
McCrohon, J. A., Jessup, W., Handelsman, D. J., and Celermajer, D. S. (1999). Circulation 99, 2317–2322.
DePasquale, J. A., Samsonoff, W. A., and Gierthy, J. F. (1994). J. Cell Sci. 107, 1241–1254.
Gronowicz, G. A. and McCarthy, M. B. (1995). Endocrinology 136, 598–608.
Pearson, D. and Sheldon, P. (1995). Adv. Exp. Med. Biol. 371, 167–170.
Lin, V. C., Ng, E. H., Aw, S. E., Tan, M. G., Ng, E. H., and Bay, B. H. (2000). Mol. Endocrinol. 14, 348–358.
Baak, J. P., Kurver, P. H., De Snoo-Niewlaat, A. J., De Graef, S., Makkink, B., and Boon, M. E. (1982). Histopathology 6, 327–339.
Wittekind, C. and Schulte, E. (1987). Ann. Quant. Cytol. Histol. 9, 480–484.
Wolberg, W. H., Street, W. N., and Magasarian, O. L. (1997). Cancer 81, 172–179.
Pokorna, E., Jordan, P. W., O’Neill, C. H., Zicha, D., Gilbert, C. S., and Vesely, P. (1994). Cell Motil. Cytoskel. 28, 25–33.
Helige, C., Zellnig, G., Hoffman-Wellenhof, R., Fink-Puches, R., Smolle, J., and Tritthart, H. A. (1997). Invas. Metast. 17, 26–41.
Bershadsky, A. D., Gluck, U., Denisenko, O. N., Sklyarova, T. V., Spector, I., and Ben-Ze’ev, A. (1995). J. Cell Sci. 180, 1183–1193.
Hazan, R. B., Kang, L., Roe, S., Borgen, P. I., and Rimm, D. L. (1997). J. Biol. Chem. 272, 32,448–32,453.
Berx, G., Nollet, F., and van Roy, F. (1998). Cell Adhes. Commun. 6, 171–184.
Fujimoto, J., Ichigo, S., Hori, M., Morishita, S., and Tamaya, T. (1996). J. Steroid Biochem. Mol. Biol. 57, 275–282.
Shi, Y. E., Liu, Y. E., Lippman, M. E., and Dickson, R. B. (1994). Hum. Reprod. 9(Suppl. 1), 162–173.
Wiebe, J. P., Deline, C., Buckingham, K. D., Dave, V., and Stothers, J. B. (1985). Steroids 45, 39–51.
Marchevsky, A. M. and Erler, B. S. (1994). In: Image analysis: a primer for pathologists. Marchevsky. A. M. and Bartels, P. H. (eds.). Raven Press, New York, pp. 125–180.
Usson, Y., Guignandon, A., Laroche, N., Lafage-Proust, M. H., and Vico, L. (1997). Cytometry 28, 298–304.
Bradford, M. M. (1976). Anal. Biochem. 72, 248–259.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wiebe, J.P., Muzia, D. The endogenous progesterone metabolite, 5α-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells. Endocr 16, 7–14 (2001). https://doi.org/10.1385/ENDO:16:1:07
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:16:1:07